Public Health England
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 2013-04-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nta.nhs.uk
Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants
Phase 4
Withdrawn
- Conditions
- VaccinationImmunization
- Interventions
- Biological: SynflorixBiological: Prevenar13
- First Posted Date
- 2016-09-29
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Public Health England
- Registration Number
- NCT02918708
- Locations
- π¬π§
Imperial Healthcare NHS Trust, London, United Kingdom
π¬π§Hertfordshire primary care, Hertfordshire, United Kingdom
Childhood Influenza Immunisation Invitation Trial in Schools
Not Applicable
Withdrawn
- Conditions
- Influenza, Human
- Interventions
- Other: Intervention letterOther: Control letterOther: Reminder
- First Posted Date
- 2016-08-30
- Last Posted Date
- 2023-04-25
- Lead Sponsor
- Public Health England
- Registration Number
- NCT02883972
PRIME Follow up - Quadri Meningo Vacinees
Completed
- Conditions
- Meningococcal Disease
- Interventions
- Other: venepuncture only
- First Posted Date
- 2016-06-23
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 57
- Registration Number
- NCT02811120
Observational Follow up of Prior HPV Vaccinees
Completed
- Conditions
- Human Papillomavirus Virus
- Interventions
- Other: venepuncture
- First Posted Date
- 2016-06-23
- Last Posted Date
- 2019-03-26
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 93
- Registration Number
- NCT02811068
- Locations
- π¬π§
Gloucestershire primary care, Gloucestershire, United Kingdom
π¬π§Hertfordshire primary care, Hertfordshire, United Kingdom
Host-pathogen Interactions in Meningococcal Disease: Finding the Key That Fits the Lock
Withdrawn
- Conditions
- Meningitis
- Interventions
- Other: Meningitis cases
- First Posted Date
- 2016-04-04
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Public Health England
- Registration Number
- NCT02727465
- Locations
- π¬π§
All NHS hospitals, England, United Kingdom
Pertussis and Meningitis C Concomitant Vaccination in Adolescents
Phase 4
Completed
- Conditions
- PertussisPreventive Immunization; MeningitisMeningitisImmunization
- Interventions
- Biological: Meningococcal vaccineDrug: Pertussis containing vaccine
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 400
- Registration Number
- NCT02526394
- Locations
- π¬π§
Gloucestershire primary care, Gloucestershire, United Kingdom
π¬π§Hertfordshire primary care, Hertfordshire, United Kingdom
A Study to Assess the Carriage of Pneumococci in Children Aged 1-5 Years, and Their Household Contacts
Completed
- Conditions
- Nasal Carriage of Pneumococci
- Interventions
- Other: nasopharyngeal swab
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 400
- Registration Number
- NCT02522546
- Locations
- π¬π§
Gloucestershire primary care, Gloucestershire, United Kingdom
π¬π§Hertfordshire primary care, Hertfordshire, United Kingdom
Improving the Detection of Active Tuberculosis in Accident and Emergency Departments
- Conditions
- Latent TuberculosisActive Tuberculosis
- Interventions
- Procedure: venepuncture, sputum collection, xray
- First Posted Date
- 2015-07-31
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 1000
- Registration Number
- NCT02512484
- Locations
- π¬π§
Barts NHS Trust, London, United Kingdom
π¬π§Ealing Hospital, London, United Kingdom
π¬π§West Middlesex Hospital NHS Trust, London, United Kingdom
A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants
Phase 4
Completed
- Conditions
- Responses to Infant Immunisations
- Interventions
- First Posted Date
- 2014-05-23
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 366
- Registration Number
- NCT02145624
- Locations
- π¬π§
Hertfordshire, Hertfordshire, United Kingdom
π¬π§Gloucestershire, Gloucestershire, United Kingdom
π¬π§St George's Vaccine Institute, London, United Kingdom
A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naΓ―ve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix β’).
- First Posted Date
- 2014-05-21
- Last Posted Date
- 2018-01-16
- Lead Sponsor
- Public Health England
- Target Recruit Count
- 300
- Registration Number
- NCT02143882
- Locations
- π¬π§
Hertfordshire, Hertfordshire, United Kingdom
π¬π§Gloucestershire, Gloucestershire, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath